Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Takeda's Interest Likely To Flush Out Further Shire Suitors

Executive Summary

As Takeda discloses that it is considering making a bid to acquire Shire, other big pharma companies look likely to assess their own interest in the firm. Pfizer and AbbVie are among those that may lay their cards on the table.


Related Content

Takeda Offers Shire Asset Disposal To Assuage EC Merger Concerns
Takeda Grabs Shire At Last After Long Pursuit
Takeda, Shire Finally Seal £46bn Deal
Shire Rejects Multiple Equity-Loaded Takeda Offers, Allergan Declines To Bid
What Will Novartis Do With $13bn Cash Pile From GSK?
Weak Rova-T Data May Imperil AbbVie's Larger Cancer Ambitions
Allergan's Restasis Defense Falters As PTAB Dismisses Tribal Immunity Ploy
Shire May Split Up – But Punting On Bigger Decisions For Now
US Policy Quick Bits: Tax Reform, Sen. Franken, And 3D-Printing
Shire & Baxalta Seal The Deal


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts